BRCA2 and ovarian carcinoma: The most recent meta-analysis by Moorman et al. is also the largest of the included studies, considering 1353 ovarian cancer cases and 2310 controls with BRCA1 mutation as well as 277 cases and 423 controls with BRCA2 mutation [15].